Trelegy vs Breztri
What to choose Trelegy or Breztri
Trelegy and Breztri are inhalers both of Control type. Trelegy and Breztri are both brand inhalers. Trelegy is manufactured by pharmaceutical company GSK, while Breztri is manufactured by AstraZeneca. The main substances of Trelegy are Fluticasone and Vilanterol. The available dosage for Trelegy is 100 mcg / 25 mcg. The main substances of Breztri are Budesonide and Formoterol. The available dosages for Breztri are 160 mcg / 4,8 mcg.
The current cost for Trelegy is roughly $619.92 while average cost for Breztri is around $556.34, said Cannon Bailey, a Scientist at the University of North Carolina at Asheville and a Medical Assistant at a clinic that uses Trelegy and Breztri.
Trelegy and Breztri Comparison
| Trelegy | Breztri | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | GSK | AstraZeneca |
| Substance: | Fluticasone + Vilanterol | Budesonide + Formoterol |
| Dosage: | 100 mcg / 25 mcg | 160 mcg / 4,8 mcg |
| Avg Price: | $619.92 | $556.34 |